| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |